Blog
RSS FeedPosted by Michael Wonder on 13 Jun 2017
Cannabis rules loosened after Senate gangs up on government
13 June 2017 - Terminally ill patients will get faster access to medicinal marijuana and be able to import their ...
Posted by Michael Wonder on 13 Jun 2017
Patients at risk as hospitals report shortages of ‘1500 life saving medicines
13 June 2017 - Australia's hospitals are running out of life-saving medicines including antibiotics and chemotherapies with more than 1500 ...
Posted by Michael Wonder on 13 Jun 2017
Generic and biosimilar prescription medicines, 2016
13 June 2017 -The generic and biosimilar prescription medicines: TGA annual summary 2016 publication provides details of all generic and ...
Posted by Michael Wonder on 26 May 2017
Investing $5.9 million to tackle antimicrobial resistance
26 May 2017 - The Australian Government will invest $5.9 million from the Medical Research Future Fund to help tackle the ...
Posted by Michael Wonder on 25 May 2017
Medical research reforms to improve our future health
25 May 2017 - The Australian Government provides more than $800 million through the National Health and Medical Research Council each ...
Posted by Michael Wonder on 02 May 2017
MSD plans 2017 launch of Renflexis (infliximab) in Australia
1 May 2017 - Latest MSD biosimilar secures TGA approval. ...
Posted by Michael Wonder on 26 Apr 2017
Changes to pharmaceutical extension of term application procedures the latest front in the battle for savings in Australia’s health care budget
26 April 2017 - It’s no secret that the Australian Government is struggling to manage the cost of its health ...
Posted by Michael Wonder on 18 Apr 2017
Submissions received and TGA response: orphan drug program
18 April 2017 - The TGA would like to thank respondents who provided submissions in response to the October 2016 ...
Posted by Michael Wonder on 10 Apr 2017
QUT, MTPConnect and industry partnership will help to ensure Australia stays globally competitive
10 April 2017 - Medicines Australia warmly welcomes the commencement of The Bridge Program – an initiative of a consortium ...
Posted by Michael Wonder on 06 Apr 2017
AusBiotech says R&D Tax Incentive critical to 2030 Innovation Strategy
6 April 2017 - Preserving the R&D Tax Incentive will be top priority as AusBiotech coordinates comment for Innovation and ...
Posted by Michael Wonder on 21 Mar 2017
TGA seeks feedback on support needs for SMEs
21 March 2017 - The TGA is investigating ways that it might provide support for small and medium enterprises in ...
Posted by Michael Wonder on 17 Mar 2017
Expedited pathways for prescription medicines
17 March 2017 - The TGA would like to thank respondents who provided submissions in response to the October 2016 ...
Posted by Michael Wonder on 16 Mar 2017
Nine submissions done and two due by month end…
16 March 2017 - Industry advocacy at AusBiotech is in ‘top gear’ with nine submissions completed on behalf of members ...
Posted by Michael Wonder on 08 Mar 2017
Donald Trump's FDA plans could affect drug regulation in Australia, leading medic warns
9 March 2017 - Drug safety and regulation in Australia are under threat from US President Donald Trump, says leading ...
Posted by Michael Wonder on 21 Feb 2017
AusBiotech suggests FSANZ amend cost recovery plan
21 February 2017 - AusBiotech has responded to Food Standards Australia New Zealand (FSANZ) call for comment on the draft ...